Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine

BACKGROUND: Viral reduction and inactivation of cell-derived biologicals is paramount for patients’ safety and so viral reduction needs to be demonstrated to regulatory bodies in order to obtain marketing authorisation. Allogeneic human blood-derived biological medicinal products require special att...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood Transfus
Hlavní autoři: Gugerell, Alfred, Sorgenfrey, Dirk, Laggner, Maria, Raimann, Jürgen, Peterbauer, Anja, Bormann, Daniel, Suessner, Susanne, Gabriel, Christian, Moser, Bernhard, Ostler, Tobias, Mildner, Michael, Ankersmit, Hendrik J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Edizioni SIMTI - SIMTI Servizi Srl 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7053523/
https://ncbi.nlm.nih.gov/pubmed/30865581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2450/2019.0249-18
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky